Clinical Trial Update: Phase 2A Clinical Trial Evaluating the Potential Activity and Safety of hMaxi-K Gene for ED [Phase 2]

View source ↗

Summary

Phase 2A trial evaluating the activity and safety of hMaxi-K gene therapy for erectile dysfunction has been completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erectile Dysfunction

Drugs mentioned

• hMaxi-K gene therapy (hMaxi-K gene therapy)

Snippet

Sponsor: Urovant Sciences GmbH | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED | Results posted: 2019-08-08